Physician profile
Kevin C Chen
NPI 1740291780
$358.32
in general payments reported to CMS, 2019-2025
8 companies · $62.51 in 2025
The $62.51 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.94 · 2020: $36.41 · 2023: $40.46 · 2024: $184 · 2025: $62.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267 · Education: $20.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.63 |
| Education | $20.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $122.45 | 2024 | Vafseo |
| Astrazeneca Pharmaceuticals LP | $62.82 | 2019-2025 | Farxiga, Lokelma |
| Fresenius USA Marketing, INC. | $46.45 | 2020-2024 | Velphoro |
| Vantive US Healthcare LLC | $37.53 | 2025 | Renal - Pd |
| Opko Pharmaceuticals, LLC | $29.63 | 2019-2020 | |
| Nxstage Medical, INC. | $21.27 | 2023 | Liberty Select Cycler |
| Travere Therapeutics, INC. | $20.34 | 2024 | |
| Ets Wound Care LLC | $17.83 | 2024 | Mirragen Advanced Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.